References
- Sugarbaker P, Gunderson L, Wittes R. Colorectal cancer. In: De Vito, Hellman, Rosenberg, eds. Cancer Principles and Practice of Oncology, Philadelphia: JB Lippincott, 1985, 795–889.
- Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program Study. J Clin Oncol, 1989; 7: 425–432.
- Rustum YM, Madajewicz S, Campbell J, et al. Clinical biochemical pharmacology 5-formyltetrahydrofolate in combination with 5-fluorouracil in patients with advanced colorectal carcinoma: correlation with clinical response. In: H.W. Bruckner and Y.M. Rustum, eds. Advances in Cancer Chemotherapy. The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination. New York: Div. of Park Row Publishers, 1984: 77–82.
- Madajewicz S, Petrelli N, Rustum YM, et al. Phase I–II trial of high dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res, 1984; 44: 4667–4669.
- Juckett DA, Rosenberg B. Actions of cis-diamminedich-loroplatinum on cell surface nucleic acids in cancer cells as determined by cell electrophoresis techniques. Cancer Res, 1982; 42: 3565–3573.
- Scanlon HK, Safirstein RL, Thies H, et al. Inhibition of amino acid transport by cis-diamminedichloroplatinum (II) derivatives in L1210 murine leukemia cells. Cancer Res, 1983; 43: 4211–4215.
- Shionoya S, Lu Y, Scanlon KJ. Properties of amino acid transport systems in K562 cells sensitive and resistent to cisdiamminedichloroplatinum (II). Cancer Res, 1986; 46: 3445–3448.
- Krebs HA, Hems R, Tyler B. The regulation of folate and methionine metabolism. Biochem J, 1976; 158: 341–353.
- Scanlon KJ, Newman Y, Lu Y, et al. Biochemical basis for cis-platin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA, 1986; 83: 8923–8925.
- Aull JL, Rice AC, Tebbetts LA. Interactions of platinum complexes with the essential and non-essential sulfhydryl groups of thymidylate synthetase. Biochem J, 1977; 16: 672–677.
- Arbuck SG. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer, 1989; 63: 1036–1044.
- Creaven PJ. 5-Fluorouracil and folinic acid: summary of clinical experience. In: Y. Rustum and J. McGuire, eds. International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. New York: Plenum Press, 1988: 303–311.
- Madajewicz S, Burk M, Dainer P, et al. Continuous infusion (CI) of 5-fluorouracil (5-FU) and cis-platin (DDP) for metastatic colorectal cancer (MCRC) and other gastrointestinal malignancies. (Abstr.) Proc Amer Assoc Cancer Res, 1988; 29: 800.
- Zamboni A, Zambruni A, Marpicati P, Gorni F, Simoncini E, Ragni F, Marini G. Treatment of advanced colorectal and gastric cancer with cis-platinum and 5-fluorouracil: A pilot study. Chemioterapia, 1986; 5: 347–350.
- Madajewicz S, Fiore JJ, Zarrabi MH. Clinical experience with 5-FU/DDP + / - OHDW combination chemotherapy in patients with advanced colorectal carcinoma. In: Y. Rustum and J. McGuire, eds. International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. New York: Plenum Press, 1988: 295–301.
- Bruckner HW. Mount Sinai clinical experience with leucovorin and 5-fluorouracil. In: Y. Rustum and J. McGuire, eds. International Symposium on the Expanding role of Folates and Fluoropyrimidines in Cancer Chemotherapy. New York: Plenum Press, 1988: 157–166.
- Machover D, Goldschmidt E, Chollet F, et al. Treatment of advanced colerectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid. J Clin Oncol, 1986; 4: 685–691.